AmeriBen / IEC Group Chooses Elsevier’s MEDai
Risk Navigator Clinical ® to provide AmeriBen with population management and analytics solution
Orlando, FL, October 15, 2012 – Elsevier’s MEDai, which empowers payers and providers to transform care delivery and streamline operations through actionable analytics, today announced a new licensing agreement with AmeriBen/IEC Group, a full-service TPA (third-party administrator) and the largest group in the Northwest possessing both human resource consulting and benefit administration services, for MEDai’s Risk Navigator Clinical ®software. MEDai’s Risk Navigator Clinical will assist AmeriBen, which manages more than 150,000 lives, in its population management.
MEDai will provide AmeriBen with Risk Navigator Clinical, a robust solution to analyze and understand their care populations, and execute on strategies to improve the quality of care, reduce costs and waste, and ultimately impact health for their members.
“Risk Navigator Clinical will help AmeriBen as a TPA to promote clinical integration and care coordination in the various employee groups we serve,” said Ben Wright, Chief Financial Officer and VP of Strategic Initiatives, AmeriBen. “We are very excited to turn membership data into actionable information from which we will be able to provide improved quality, better outcomes in delivered care and reduced costs through analytical modeling to our clients.”
Risk Navigator Clinical leverages predictive analytics to transform raw data into intelligent insight that payers can use to allocate resources efficiently and intervene before adverse, costly outcomes occur. Through an easy-to-use web interface, Risk Navigator’s results outline areas that provide the greatest potential for intervention and management, allowing stakeholders to improve operations and set competitive premium rates.
“We are pleased to integrate Risk Navigator Clinical into AmeriBen to help it manage its clients’ populations, cut costs and improve overall health though analytic modeling,” said Thomas Zajac, President of Elsevier’s MEDai. “Both AmeriBen/IEC Group and MEDai believe that this relationship translates into a powerful new value proposition for the many members overseen by AmeriBen.”
For more information, please visit www.medai.com or call +1-800-446-3324.
# # #
AmeriBen is based in Meridian, Idaho, with additional offices in Salt Lake City, Phoenix, Denver, and Portland. AmeriBen currently administers benefit plans for over 85 employers and universities numbering 250,000 participant and student lives. AmeriBen’s focus on providing access to best in class networks, organic growth and controlling medical trend has provided opportunities for double-digit growth annually. For more information about AmeriBen visit www.ameriben.com.
About Elsevier’s MEDai
Elsevier’s MEDai, Inc., is a premier provider of advanced analytic solutions and innovative transformation and advisory services for payers, providers, ACOs and other healthcare entities. Utilizing our proprietary predictive analytics and clinical technologies, we transform the data stream in healthcare environments to improve care quality, reduce costs, and manage population health. We empower our customers to assess and stratify patients and populations, predict risk, identify cost drivers, forecast future health costs, and drive decisions that improve outcomes. For more information on MEDai, visit www.medai.com.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
Director, Corporate Relations
+1 212 633 3164